Not exact matches
While one drug, MEK inhibitor, is usually used in advanced - stage melanoma, the other drug, CDK4 / 6 inhibitor, palbociclib, is currently FDA - approved
for treatment of
Estrogen Receptor -
positive breast cancer patients.
In the second study, researchers examined whether aspirin is associated with
breast density, which is a widely accepted risk factor
for both
estrogen receptor minus (ER --RRB- and
estrogen receptor positive (ER +)
breast cancers, and can be a key factor in detecting tumors during routine mammograms.
«Novel therapeutic target discovered
for estrogen receptor positive (ER +)
breast cancer.»
It was used in this study
for the first time to study factors that cause
estrogen receptor positive breast cancer to recur during tamoxifen therapy.
Excess
estrogen is a problem
for women predisposed to
estrogen receptor positive breast cancers.
As has been suspected by many in the natural health community
for a while, research from the University of Illinois has confirmed that the concentration of soy isoflavone in supplements may help drive tumor growth in women with
estrogen -
receptor positive breast cancer.
High dietary intake of soy isoflavones was associated with lower risk of recurrence among post-menopausal patients with
breast cancer positive for estrogen and progesterone
receptor and those who were receiving anastrozole as endocrine therapy.
Let's bump it up a notch: not just soy, but soy
for women with active
estrogen receptor -
positive breast cancer.
These findings are incredibly good news
for women diagnosed with
estrogen receptor positive / progesterone
receptor positive breast cancers.